Journals / Adıyaman Üniversitesi Sağlık Bilimleri Dergisi / 2018 / Cilt: 4 - Sayı: 3

The effects of transfer day in intracytoplasmic sperm injection (ICSI) pregnancies on first trimester screening test results

Pages
1083–1093
Publication Date
2018-12-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These outcomes are likely to be because of changings in the placenta of ART pregnancies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objects: To compare first trimesterscrening (FTS) serum markers free β-human chorionic gonodotropin (free β-hCG and pregnancy associated plasma protein A (PAPP-A) of blastocyst versus cleavage stage embryo transfers after assisted reproductive technologies (ART).Methods: Retrospective examinations of 123 women who conceived with ART were subjected to FTS from January 2017 to December 2017 at Bahçeşehir University Göztepe Medical Park Hospital In Vitro Fertilization (IVF) Unit.The age,gestational week,ultrasound (US) markers and biochemistry markers(PAPP-A,free β-hCG) were collected.Outcomes were regarded as meaningful when the p < 0.05.
📊
Key Findings & Data:Statistical Package For Social Sciences (SPSS) v.17.0 for Windows was preferred to make statistical analysis.Results: PAPP-A amounts were remarkably low in day-3 (cleavage stage embryos) transfer intracytoplasmic sperm injection (ICSI) pregnancies compared to day-5 (blastocyst stage embryos) transfer ICSI pregnancies.Free β-hCG amounts weren’t significantly different in two groups (p=0.371).
💡
Conclusion & Impact:These outcomes are likely to be because of changings in the placenta of ART pregnancies.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Assisted reproduction techniques · blastocyst · cleavage

Abstract

Objects: To compare first trimesterscrening (FTS) serum markers free β-human chorionic gonodotropin (free β-hCG and pregnancy associated plasma protein A (PAPP-A) of blastocyst versus cleavage stage embryo transfers after assisted reproductive technologies (ART).Methods: Retrospective examinations of 123 women who conceived with ART were subjected to FTS from January 2017 to December 2017 at Bahçeşehir University Göztepe Medical Park Hospital In Vitro Fertilization (IVF) Unit.The age,gestational week,ultrasound (US) markers and biochemistry markers(PAPP-A,free β-hCG) were collected.Outcomes were regarded as meaningful when the p < 0.05. Statistical Package For Social Sciences (SPSS) v.17.0 for Windows was preferred to make statistical analysis.Results: PAPP-A amounts were remarkably low in day-3 (cleavage stage embryos) transfer intracytoplasmic sperm injection (ICSI) pregnancies compared to day-5 (blastocyst stage embryos) transfer ICSI pregnancies.Free β-hCG amounts weren’t significantly different in two groups (p=0.371). NT was unaffected by the transferenceday (p=0.21). Also CRL wasunaffected by the transferenceday (p=0.693). No differences appeared between 3rd and 5th day embryo transference according to maternal age (p=0.616), weight (p=0.693) and gestational age (p=0.742) at sampling. Conclusion: Today, the datas about the effects of ART over the ingredients of combined FTS for chromosomal analysis are contentious yet.Day-3 ICSI pregnancies had meaningfully low PAPP-A amounts which support the requirement to properly set the combined FTS risks algoritm. These outcomes are likely to be because of changings in the placenta of ART pregnancies.

Özet

Objects To compare first trimester screning serum markers free β-human chorionic gonodotropin (free β-hCG and pregnancy associated plasma protein A (PAPP-A) of blastocyst versus cleavage stage embryo transfers after assisted reproductive technologies (ART) . Methods Retrospective analysis of 123 women who conceived with ART undergone first-trimester screening between January 2017 and December 2017 at Bahçeşehir University Göztepe Medical Park Hospital IVF Unit. The age, gestational week, ultrasound markers and biochemistry markers (PAPP- A,free β-hCG) were collected. Results were considered significant when the p value was less than 0.05. Statistical Package For Social Sciences (SPSS) version 17.0 for Windows was used for statistical analysis. Results PAPP-A levels were significantly lower in day-3 (cleavage stage embryos) transfer intracytoplasmic sperm injection (ICSI) pregnancies compared to day-5 (blastocyst stage embryos) transfer ICSI pregnancies (p<0.05). Free β-hCG levels weren’t significantly differ in two groups (p=0.371). NT was unaffected by the day of transfer (p=0.21). Also CRL wasn’t affected by the day of transfer (p=0.693). No differences appeared between day-3 and day-5 embryo transfer with respect to maternal age ,(p=0.616) weight (p=0.693) and gestational age (p=0.742) at sampling. Conclusion Today, the data on the effect of ART on the components of first trimester combined screening for chromosomal analysis are still controversial. Day-3 ICSI pregnancies had significantly lower PAPP-A levels supporting the need to appropriately adjust the combined first trimester screening (cFTS) risk algoritm. These results may be due to alterations in the placentation of ART pregnancies.

🔖

Cite This Article

GÜNGÖR, N. D., GÜRBÜZ, T., ERŞAHİN, A. (2018). The effects of transfer day in intracytoplasmic sperm injection (ICSI) pregnancies on first trimester screening test results. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 4 - Sayı: 3, 1083–1093. https://ajindex.com/articles/727282

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Mangalraj AM, Muthukumar K, Aleyamma T, Kamath MS, George K. Blastocyst stage transfer vs cleavage stage embryo transfer. J Hum Reprod Sci 2009
  2. 23–6. 2.Karaki RZ, Samarraie SS, Younis NA, Lahloub TM, Ibrahim MH. Blastocyst culture andtransfer: a step toward improved in vitro fertilization outcome. Fertil Steril 2002
  3. Edwards RG, Beard HK. Blastocyst stage transfer: pitfalls and benefits. Hum Reprod. 1999
  4. 1–4. 4.Gardner DK, Lane M. Culture and selection of viable blastocysts: a feasible proposition for human IVF? Hum Reprod Update. 1997
  5. 367–82. 5.Pool TB, Atiee SR, Martin JE. Oocyte and embryo culture: basic concepts and recent advances. Infert Reprod Med Clinics N Amer. 1998
  6. 181–203. 6.Tsirigotis M. Blastocyst stage transfer: pitfalls and benefits. Too soon to abandon current practice? Hum Reprod. 1998
  7. 3285–89. 7.Gardner DK, Schoolcraft WB. No longer neglected: the human blastocyst. Hum Reprod. 1998
  8. 3289–92. 8.Gardner DK, Balaban B. Choosing between day 3 and day 5 embryo transfers. Clin Obstet Gynecol. 2006
  9. 85–92. 9.Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003
  10. 313–21. 10.Royal Australian and New Zealand College of Obstetricians and Gynaecologists and Human Genetics Society of Australasia. Prenatal screening tests for trisomy 21 (Down syndrome), trisomy18 (Edwards syndrome) and neural tube defects. Victoria: RoyalAustralian and New Zealand College of Obstetricians andGynaecologists
  11. Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn 2011
  12. Sonek J, Nicolaides KH. Additional first-trimester ultrasound markers. Clin Lab Med 2010
  13. Kagan KO, Wright D, Spencer K et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008
  14. Chitayat DS, Langlois S, Wilson RD. Prenatal screening for fetal aneuploidy in singleton pregnancies. J Obstet Gynaecol Can 2011
  15. Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010
  16. Klemetti R, Gissler M, Hemminki E. Comparison of perinatal health of children born from IVF in Finland in the early and late 1990s. Hum Reprod. 2002
  17. 17(8):2192–8. 17.Wright VC, Chang J